Unpacking New Data From 2024 Congresses on Transthyretin Amyloid Cardiomyopathy
17.12.2024
0:00
32:29
Are you up to date on the new developments for emerging therapies for your patients with transthyretin amyloid cardiomyopathy (ATTR-CM)?
Credit available for this activity expires: 12/16/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002007?ecd=bdc_podcast_libsyn_mscpedu
Weitere Episoden von „Keeping Current CME“
Verpasse keine Episode von “Keeping Current CME” und abonniere ihn in der kostenlosen GetPodcast App.